The binding leads to nuclear translocation of PKM2, where it acts as protein kinase and interacts with other molecules to control the expression of vascular endothelial growth factor (VEGF), thereby promoting tumor angiogenesis (61). This evidence concerns the gene PKM and neoplasm.